Bill Text: NY A04141 | 2023-2024 | General Assembly | Amended

---

Bill Title: Prohibits cost sharing for insulin; provides that an insured shall not be subject to a deductible, copayment, coinsurance or any other cost sharing requirement for the purchase of insulin.

Spectrum: Moderate Partisan Bill (Democrat 47-13)

Status: (Introduced) 2024-01-25 - print number 4141a [A04141 Detail]

Download: New_York-2023-A04141-Amended.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                         4141--A

                               2023-2024 Regular Sessions

                   IN ASSEMBLY

                                    February 10, 2023
                                       ___________

        Introduced  by M. of A. FORREST, RAGA, GALLAGHER, SHRESTHA, GONZALEZ-RO-
          JAS, ARDILA, ALVAREZ, DARLING, AUBRY, SIMON, COLTON, BURDICK, MAMDANI,
          CHANDLER-WATERMAN, MITAYNES, MEEKS, STECK, KELLES, BLUMENCRANZ, DeSTE-
          FANO,  WALKER,  SEPTIMO,  TAPIA,  TAYLOR,  THIELE,  ANDERSON,   TAGUE,
          BENDETT, HYNDMAN, DICKENS, DURSO, SIMONE, EPSTEIN, CRUZ, DAVILA, COOK,
          SHIMSKY,  LUNSFORD,  BORES, CURRAN, LEVENBERG, FLOOD, MAHER, JACOBSON,
          BURGOS, HUNTER, CUNNINGHAM, RAJKUMAR, CARROLL, SANTABARBARA,  JACKSON,
          CLARK,  REYES  -- read once and referred to the Committee on Insurance
          -- recommitted to the Committee on Insurance in accordance with Assem-
          bly Rule 3, sec. 2 --  committee  discharged,  bill  amended,  ordered
          reprinted as amended and recommitted to said committee

        AN ACT to amend the insurance law, in relation to prohibiting cost shar-
          ing for insulin

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subparagraph (B) of paragraph 15-a  of  subsection  (i)  of
     2  section  3216  of the insurance law, as amended by section 1 of part DDD
     3  of chapter 56 of the laws of 2020, is amended to read as follows:
     4    (B) Such coverage may be subject to annual deductibles and coinsurance
     5  as may be deemed appropriate by the superintendent and as are consistent
     6  with those  established  for  other  benefits  within  a  given  policy;
     7  provided  however, [the total amount] that [a covered person is required
     8  to pay out of pocket for] covered prescription insulin drugs  shall  [be
     9  capped  at  an  amount  not to exceed one hundred dollars per thirty-day
    10  supply, regardless of the amount or type of insulin needed to fill  such
    11  covered  person's  prescription  and regardless of the insured's] not be
    12  subject to a deductible, copayment, coinsurance or any other cost  shar-
    13  ing requirement.
    14    § 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221
    15  of  the insurance law, as amended by section 2 of part DDD of chapter 56
    16  of the laws of 2020, is amended to read as follows:

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02649-03-4
        A. 4141--A                          2

     1    (B) Such coverage may be subject to annual deductibles and coinsurance
     2  as may be deemed appropriate by the superintendent and as are consistent
     3  with those  established  for  other  benefits  within  a  given  policy;
     4  provided  however, [the total amount] that [a covered person is required
     5  to  pay  out of pocket for] covered prescription insulin drugs shall [be
     6  capped at an amount not to exceed one  hundred  dollars  per  thirty-day
     7  supply,  regardless of the amount or type of insulin needed to fill such
     8  covered person's prescription and regardless of the  insured's]  not  be
     9  subject  to a deductible, copayment, coinsurance or any other cost shar-
    10  ing requirement.
    11    § 3. Paragraph 2 of subsection (u) of section 4303  of  the  insurance
    12  law,  as  amended  by section 3 of part DDD of chapter 56 of the laws of
    13  2020, is amended to read as follows:
    14    (2) Such coverage may be subject to annual deductibles and coinsurance
    15  as may be deemed appropriate by the superintendent and as are consistent
    16  with those  established  for  other  benefits  within  a  given  policy;
    17  provided  however, [the total amount] that [a covered person is required
    18  to pay out of pocket for] covered prescription insulin drugs  shall  [be
    19  capped  at  an  amount  not to exceed one hundred dollars per thirty-day
    20  supply, regardless of the amount or type of insulin needed to fill  such
    21  covered  person's  prescription  and regardless of the insured's] not be
    22  subject to a deductible, copayment, coinsurance or any other cost  shar-
    23  ing requirement.
    24    § 4. This act shall take effect January 1, 2025 and shall apply to any
    25  policy  or contract issued, renewed, modified, altered, or amended on or
    26  after such date.